Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CER Will Accelerate Copay Incentives In Private Coverage, United Exec Says

Executive Summary

The increasing availability of comparative effectiveness data on drug treatments will foster broader use of copay structures that discourage patients from seeking higher cost treatments that offer no real benefit over lower cost drugs, UnitedHealthcare Senior VP-Oncology Lee Newcomer predicted at a conference on CER and personalized medicine held at the National Institutes of Health Oct. 20.

You may also be interested in...



United Healthcare Tackles Cancer Drug Costs With Bundled Payments To Physicians

United Healthcare launches pilot program that will eliminate the markup on chemotherapy drugs as an incentive for prescribing.

One To Watch: CMS Innovation Center Gets Chief, High-Priority Focus

The new payment innovation center at the Centers for Medicare and Medicaid Services is shaping up as a high-priority program for the agency, as demonstrated by the recent appointment of former Geisinger executive Richard Gilfillan to head the unit.

MedPAC Considering Two Options For Reinstating Medicare Least Costly Alternative Policy For Drugs

Both proposals involve legislation that would authorize Medicare Part B to pay for drugs based on the price of the lowest-cost alternative.

Related Content

Topics

UsernamePublicRestriction

Register

PS052745

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel